RALLISNSEQ4 & FY23April 25, 2023

Rallis India Limited

1,937words
2turns
0analyst exchanges
0executives
Key numbers — 31 extracted
rs,
ed. Important factors that could make a difference to the Company’s operations include, among others, economic conditions affecting demand / supply, price conditions in the domestic and overseas market
80%
iness (Herbicides, Insecticides, Fungicides) Well entrenched connect with farmers covering 80% of India’s districts efforts on Research focused developing customized products and pac
10%
oconazole): F- Grapes, F&V Themifit (Thiophanate Methyl), F- Multiple Crops Mahat (Pyrazosulfuron 10% WP), H-Paddy Co-Marketing Dext (Fipronil): I-Paddy, Sugarcane Kevat Ultra (Pyrithiobac + Quizal
63%
pabilities IBD REVENUE REVENUE MIX ₹ Crs FY22 FY23 FY25 E INTERNATIONAL DOMESTIC 63% ● Despite challenges, Exports growth on good momentum. Continue the journey towards increasing
40%
challenges, Exports growth on good momentum. Continue the journey towards increasing the share to 40% share in Crop care revenue by FY25E ● Significant market share in 2 a.i.s and dominant across the
14%
rogress on the emerging CM opportunities Copyright © Rallis India Limited. All rights reserved. 14% CAGR DOMESTIC CROP NUTRITION focus on Complete non-subsidized fertilizers and crop nutrien
20%
owing segment Well defined product portfolio covering diverse segments across various crops 20% growth p.a. in last 5 years Good future potential to grow given the market situation and po
3%
NANCIAL SNAPSHOT – Q4, FY23 REVENUE EBITDA PAT AEI ₹ Crs • • • Q4FY23 Revenue grew by 3% over PY Q4 Full year revenue growth at 14% Q4FY23 Crop Care revenue grew by 3% largely driven b
16%
Q4FY23 Crop Care revenue grew by 3% largely driven by International business. Full year growth of 16% Q4FY23 Seeds revenue is ₹25 Crs Vs ₹26 Crs PY Q4. Full year revenue de-grew by 1% • • • Gro
₹25
by 3% largely driven by International business. Full year growth of 16% Q4FY23 Seeds revenue is ₹25 Crs Vs ₹26 Crs PY Q4. Full year revenue de-grew by 1% • • • Gross margins lower due to high co
₹26
ely driven by International business. Full year growth of 16% Q4FY23 Seeds revenue is ₹25 Crs Vs ₹26 Crs PY Q4. Full year revenue de-grew by 1% • • • Gross margins lower due to high cost volatil
1%
ear growth of 16% Q4FY23 Seeds revenue is ₹25 Crs Vs ₹26 Crs PY Q4. Full year revenue de-grew by 1% • • • Gross margins lower due to high cost volatility mitigated through agile pricing and pr
Guidance — 2 items
STRENGTHEN CAPABILITY
opening
14% CAGR DOMESTIC CROP NUTRITION focus on Complete non-subsidized fertilizers and crop nutrients - a niche and growing segment Well defined product portfolio covering diverse segments across various crops 20% growth p.a.
STRENGTHEN CAPABILITY
opening
Impairment of Intangible asset in Seeds Impairment of few Hybrid development programs in line with the recalibrated strategy 13.0 39.8 52.8 6.8 23.6 30.4 Total 19.8 63.4 83.2 Project “Fit” launched to make the Seeds business profitable and improve ROCEs 12 DOMESTIC MARKET DEVELOPMENT PRODUCT PROMOTION FARMER ENGAGEMENT CHANNEL ENGAGEMENT Copyright © Rallis India Limited.
Advertisement
Risks & concerns — 2 flagged
Full year EBITDA at ₹ 219 Crs • • Lower cash and higher borrowings further compress “Other Income” and increase Finance Costs Depreciation on additional capex plant including commissioned has an impact of ₹ 17 Crs for the year formulation Moderate revenue growth in a lean quarter.
STRENGTHEN CAPABILITY
• • • Margins sustained in domestic business, in continued Margin International business pressures PAT is reflective of EBITDA trend additional capex Depreciation on including plant commissioned has an impact of ₹ 17 Crs for the year formulation • Increase in market facing expenses & additional provision of ₹ 4.6 Crs recognised for the notice served by MBPT during the year Copyright © Rallis India Limited.
STRENGTHEN CAPABILITY
Speaking time
STRENGTHEN CAPABILITY
1
FOR ANY QUERIES PLEASE CONTACT BELOW
1
Advertisement
Opening remarks
STRENGTHEN CAPABILITY
PEOPLE & PROCESS DCP – Domestic Crop Protection; IB – International Business; DCN – Domestic Crop Nutrition; MPP’s – Multi Purpose Plants Copyright © Rallis India Limited. All rights reserved. SERVING FARMERS THROUGH SCIENCE DOMESTIC CROP PROTECTION Focused on 3 pillars - Extend portfolio offerings, Strengthen manufacturing and Widen markets Comprises of domestic branded formulations and Institutional business (Herbicides, Insecticides, Fungicides) Well entrenched connect with farmers covering 80% of India’s districts efforts on Research focused developing customized products and packages of practices by understanding their emerging needs category, Identified segment and portfolio gaps product for future development. Various segments across categories have been chosen for new product development and commercialization New Product launches in FY23 9(3) products Daksh Plus (Pendimethalin + Metribuzin), H-Wheat Clasto (Pyrifluquinazon): I-Cotton Whitefly Capstone (Fenoxanil + Isoprothiolan
FOR ANY QUERIES PLEASE CONTACT BELOW
Subhra Gourisaria subhra.gourisaria@rallis.com Vijay Furia vijay.furia@rallis.com Gavin Desa gavin@cdr-india.com E-mail ID/s Suraj Digawalekar suraj@cdr-india.com SERVING FARMERS THROUGH SCIENCE Registered Office Rallis India Limited 23rd Floor, Vios Tower, New Cuffe Parade, Off Eastern Freeway, Wadala, Mumbai - 400037 CIN: L36992MH1948PLC014083 Tel. No.: +91 22 6232 7400 E-mail address: investor_relations@rallis.com Website: www.rallis.com Copyright © Rallis India Limited. All rights reserved.
Advertisement
← All transcriptsRALLIS stock page →